ILMN |
Illumina, Inc. |
21.73B |
5.79% |
|
|
|
|
|
136.99 |
4.03% |
39.21% |
23.33% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
31.83B |
5.42% |
|
|
|
|
|
246.80 |
-0.80% |
45.69% |
29.50% |
---|
UTHR |
United Therapeutics Corporation |
16.40B |
5.33% |
|
|
|
|
|
367.36 |
0.83% |
34.18% |
76.88% |
---|
AMGN |
Amgen Inc. |
155.83B |
5.17% |
|
|
|
|
|
289.90 |
0.71% |
51.85% |
92.17% |
---|
BIIB |
Biogen Inc. |
23.03B |
4.77% |
|
|
|
|
|
158.01 |
1.29% |
30.76% |
40.69% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
80.46B |
4.14% |
|
|
|
|
|
744.50 |
0.15% |
30.82% |
65.68% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
12.09B |
4.11% |
|
|
|
|
|
63.45 |
1.42% |
31.72% |
30.63% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.66B |
4.06% |
|
|
|
|
|
125.00 |
1.39% |
26.05% |
22.51% |
---|
XNCR |
Xencor, Inc. |
1.69B |
3.59% |
|
|
|
|
|
24.10 |
1.60% |
66.38% |
43.21% |
---|
MNKD |
MannKind Corporation |
1.90B |
3.54% |
|
|
|
|
|
6.90 |
0.29% |
67.79% |
27.80% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.48B |
3.26% |
|
|
|
|
|
41.65 |
2.46% |
63.59% |
23.14% |
---|
EXEL |
Exelixis, Inc. |
9.95B |
3.15% |
|
|
|
|
|
34.83 |
0.52% |
30.45% |
21.53% |
---|
CPRX |
Catalyst Pharmaceuticals, Inc. |
2.52B |
3.05% |
|
|
|
|
|
21.12 |
-0.14% |
38.85% |
28.54% |
---|
VCYT |
Veracyte, Inc. |
3.02B |
3.00% |
|
|
|
|
|
38.94 |
-0.66% |
61.47% |
24.06% |
---|
TGTX |
TG Therapeutics, Inc. |
5.38B |
2.94% |
|
|
|
|
|
34.55 |
10.91% |
76.64% |
48.95% |
---|
INCY |
Incyte Corporation |
13.56B |
2.89% |
|
|
|
|
|
70.39 |
-0.93% |
52.27% |
70.92% |
---|
NTRA |
Natera, Inc. |
22.36B |
2.85% |
|
|
|
|
|
169.36 |
0.88% |
44.35% |
31.38% |
---|
TECH |
Bio-Techne Corporation |
11.29B |
2.81% |
|
|
|
|
|
71.05 |
3.39% |
31.91% |
33.23% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.55B |
2.81% |
|
|
|
|
|
7.49 |
2.60% |
48.42% |
10.43% |
---|
RGEN |
Repligen Corporation |
7.94B |
2.70% |
|
|
|
|
|
141.76 |
2.06% |
49.02% |
45.57% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
980.73M |
2.67% |
|
|
|
|
|
30.41 |
1.37% |
64.99% |
64.91% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.69B |
2.65% |
|
|
|
|
|
16.18 |
-0.55% |
59.88% |
30.50% |
---|
QGEN |
Qiagen N.V. |
9.39B |
2.63% |
|
|
|
|
|
42.33 |
0.57% |
31.87% |
59.67% |
---|
BPMC |
Blueprint Medicines Corporation |
6.14B |
2.58% |
|
|
|
|
|
96.62 |
1.91% |
49.15% |
17.43% |
---|
NVAX |
Novavax, Inc. |
1.29B |
2.54% |
|
|
|
|
|
8.04 |
-0.25% |
72.01% |
29.61% |
---|
OPK |
OPKO Health, Inc. |
1.06B |
2.51% |
|
|
|
|
|
1.5600 |
-1.27% |
100.31% |
30.70% |
---|
VCEL |
Vericel Corporation |
2.80B |
2.38% |
|
|
|
|
|
56.71 |
-0.96% |
55.01% |
23.93% |
---|
MYGN |
Myriad Genetics, Inc. |
1.38B |
2.28% |
|
|
|
|
|
15.12 |
-1.18% |
53.88% |
59.47% |
---|
HALO |
Halozyme Therapeutics, Inc. |
5.81B |
2.27% |
|
|
|
|
|
45.70 |
-0.13% |
49.04% |
51.89% |
---|
CDNA |
CareDx, Inc |
1.21B |
2.05% |
|
|
|
|
|
22.58 |
0.94% |
100.69% |
30.53% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.05% |
|
|
|
|
|
|
|
|
|
---|